11th Annual Discovery on Target
Conference - Boston, MA, US
Produced by Cambridge Healthtech Institute (CHI), the 11th Annual International Drug Discovery on Target is the premier event showcasing current and emerging "hot" targets for the pharmaceutical industry. Spanning three days, the meeting attracts over 630+ attendees (from 24 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. The meeting is comprised of 11 meeting tracks which include Targeting Epigenetic Readers; Targeting Histone Methyltransferases; Next Generation Histone Deacetylase Inhibitors; Targeting Histone Demethylases; GPCR-Based Drug Discovery; GPCR-Targeted Therapeutics; Functional Genomics Screening Strategies; Novel Strategies for Kinase Inhibitors; Antibodies against Membrane Protein Targets; and Cardio-Metabolic Drug Targets. The 2013 event will offer 150+ scientific presentations across these 11 conference tracks and 10 pre-conference short courses, 30+ interactive breakout discussion groups, an exhibit hall of 30+ companies, and dedicated poster viewing and networking sessions. The 11th Annual International Drug Discovery on Target assembles an impressive group of 175+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
(Courtesy of Discovery on Target 2013 Conference's logo, via chicorporate.com)
Web page: http://www.discoveryontarget.com/
September 24, 2013 - September 26, 2013
Westin Boston Waterfront, Boston, Massachusetts, USA
Contact:Kris Waterman (kwaterman@healthtech.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
